Dual Use of Artificial Intelligence-powered Drug Discovery
- PMID: 36211133
- PMCID: PMC9544280
- DOI: 10.1038/s42256-022-00465-9
Dual Use of Artificial Intelligence-powered Drug Discovery
Abstract
An international security conference explored how artificial intelligence (AI) technologies for drug discovery could be misused for de novo design of biochemical weapons. A thought experiment evolved into a computational proof.
Conflict of interest statement
Competing interests F.U. and S.E. work for Collaborations Pharmaceuticals, Inc. F.L. and C.I. have no conflicts of interest.
Figures

References
-
- Blaschke T et al. J Chem Inf Model 60, 5918–5922, (2020). - PubMed
-
- Anon <https://www.ncbi.nlm.nih.gov/books/NBK233724/> (1997).
Grants and funding
LinkOut - more resources
Full Text Sources